Sign in
Back
Cardiovascular risk reduction throughout GLP-1 receptor agonist and SGLT2 inhibitor modulation of epicardial fat
Journal article   Peer reviewed

Cardiovascular risk reduction throughout GLP-1 receptor agonist and SGLT2 inhibitor modulation of epicardial fat

G Iacobellis and M. G Baroni
Journal of endocrinological investigation
2021-10-13
DOI: https://doi.org/10.1007/s40618-021-01687-1
PMID: 34643917

Metrics

57 Record Views
17 Times Cited - Web of Science

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
International collaboration
Citation topics
1 Clinical & Life Sciences
1.26 Diabetes
1.26.107 Adiponectin
Web Of Science research areas
Endocrinology & Metabolism
ESI research areas
Biology & Biochemistry

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Details